Novel Antibody Drug Conjugates Targeting Tumor-Associated Receptor Tyrosine Kinase ROR2 by Functional Screening of Fully Human Antibody Libraries Using Transpo-mAb Display on Progenitor B Cells.

Autor: Hellmann I; NBE-Therapeutics Ltd., Basel, Switzerland., Waldmeier L; NBE-Therapeutics Ltd., Basel, Switzerland., Bannwarth-Escher MC; NBE-Therapeutics Ltd., Basel, Switzerland., Maslova K; NBE-Therapeutics Ltd., Basel, Switzerland., Wolter FI; NBE-Therapeutics Ltd., Basel, Switzerland., Grawunder U; NBE-Therapeutics Ltd., Basel, Switzerland., Beerli RR; NBE-Therapeutics Ltd., Basel, Switzerland.

Publikováno v: Frontiers in immunology [Front Immunol] 2018 Nov 02; Vol. 9, pp. 2490. Date of Electronic Publication: 2018 Nov 02 (Print Publication: 2018).